Apellis Pharmaceuticals APLS 深 滬
等待開盤 09-20 09:30:00 美东时间
36.73
+1.100
+3.09%
華盛通- 最 高37.835
- 今 開36.24
- 成交量 176.01万股
- 最 低 36.10
- 昨 收 35.63
- 總市值 44.44亿
- 52周最高 73.80
- 市盈率 靜 --
- 換手率 1.45%
- 52周最低 33.49
- 委 比 -30.79%
- 總股本 1.21亿
- 歷史最高 94.75
- 量 比 1.23
- 振 幅 4.87%
- 歷史最低 11.45
- 每 手 1
- 風險率 10.58%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Apellis Pharmaceuticals (APLS) Gets a Hold from Mizuho Securities
Mizuho Securities analyst Graig Suvannavejh maintained a Hold rating on Apellis...
09-16 14:25
Analyst Scoreboard: 15 Ratings For Apellis Pharmaceuticals
Across the recent three months, 15 analysts have shared their insights on Apell...
09-14 05:01
快讯 | Apellis Pharmaceuticals Inc：瑞穗将目标价从42美元下调至39美元
Apellis Pharmaceuticals Inc : Mizuho Cuts Target Price to $39 From $42
09-13 18:40
Apellis Pharmaceuticals, Inc.'s (NASDAQ:APLS) Profit Outlook
We feel now is a pretty good time to analyse Apellis Pharmaceuticals, Inc.'s (N...
08-23 21:33
快讯 | Apellis制药公司：摩根大通将目标价从72美元下调至64美元
Apellis Pharmaceuticals Inc : JP Morgan Cuts Target Price to $64 From $72
08-13 10:58
快讯 | Apellis药品公司：瑞银将目标价从85美元下调至83美元
Apellis Pharmaceuticals Inc : UBS Cuts Target Price to $83 From $85
08-09 22:13
快讯 | Apellis制药公司：Jefferies将目标价从80美元上调至82美元
Apellis Pharmaceuticals Inc : Jefferies Raises Target Price to $82 From $80
08-09 16:48
快讯 | Apellis Pharmaceuticals股份有限公司：Baird将目标价从86美元上调至96美元。
Apellis Pharmaceuticals Inc : Baird Raises Target Price to $96 From $86
08-08 23:21
Apellis stock jumps as rare kidney disease therapy succeeds in trial
Apellis Pharmaceuticals (NASDAQ:APLS) and partner Sobi’s experimental rare kidney disease therapy pegcetacoplan has met the primary endpoint in a Phase 3 trial. The VALIANT trial is evaluating pegceta...
08-08 19:54
快讯 | Apellis和Sobi宣布C3G和Primary Ic-Mpgn的Pegcetacoplan III期Valiant研究取得了积极的顶线结果。
Apellis and Sobi Announce Positive Topline Results From Phase 3 Valiant Study o...
08-08 19:00
